Machine Learning to Compare Frequent Medical Problems of African American and Caucasian Diabetic Kidney Patients
4
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: End-stage renal disease (ESRD), which is primarily a consequence of diabetes mellitus, shows an exemplary health disparity between African American and Caucasian patients in the United States. Because diabetic chronic kidney disease (CKD) patients of these two groups show differences in their medical problems, the markers leading to ESRD are also expected to differ. The purpose of this study was, therefore, to compare their medical complications at various levels of kidney function and to identify markers that can be used to predict ESRD. Methods: The data of type 2 diabetic patients was obtained from the 2012 Cerner database, which totaled 1,038,499 records. The data was then filtered to include only African American and Caucasian outpatients with estimated glomerular filtration rates (eGFR), leaving 4,623 records. A priori machine learning was used to discover frequently appearing medical problems within the filtered data. CKD is defined as abnormalities of kidney structure, present for >3 months. Results: This study found that African Americans have much higher rates of CKDrelated medical problems than Caucasians for all five stages, and prominent markers leading to ESRD were discovered only for the African American group. These markers are high glucose, high systolic blood pressure (BP), obesity, alcohol/drug use, and low hematocrit. Additionally, the roles of systolic BP and diastolic BP vary depending on the CKD stage. Conclusions: This research discovered frequently appearing medical problems across five stages of CKD and further showed that many of the markers reported in previous studies are more applicable to African American patients than Caucasian patients.
Abstract
Objectives: End-stage renal disease (ESRD), which is primarily a consequence of diabetes mellitus, shows an exemplary health disparity between African American and Caucasian patients in the United States. Because diabetic chronic kidney disease (CKD) patients of these two groups show differences in their medical problems, the markers leading to ESRD are also expected to differ. The purpose of this study was, therefore, to compare their medical complications at various levels of kidney function and to identify markers that can be used to predict ESRD. Methods: The data of type 2 diabetic patients was obtained from the 2012 Cerner database, which totaled 1,038,499 records. The data was then filtered to include only African American and Caucasian outpatients with estimated glomerular filtration rates (eGFR), leaving 4,623 records. A priori machine learning was used to discover frequently appearing medical problems within the filtered data. CKD is defined as abnormalities of kidney structure, present for >3 months. Results: This study found that African Americans have much higher rates of CKDrelated medical problems than Caucasians for all five stages, and prominent markers leading to ESRD were discovered only for the African American group. These markers are high glucose, high systolic blood pressure (BP), obesity, alcohol/drug use, and low hematocrit. Additionally, the roles of systolic BP and diastolic BP vary depending on the CKD stage. Conclusions: This research discovered frequently appearing medical problems across five stages of CKD and further showed that many of the markers reported in previous studies are more applicable to African American patients than Caucasian patients.
참고문헌 (29)
- Agodoa L, "Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans", Semin Dial, 20(6), pp.577~585 (2007)
- "Diabetic kidney disease: What is diabetic kidney disease?" (2017)[URL]
- "High blood pressure & kidney disease" (2017)[URL]
- "Anemia and chronic kidney disease" (2017)[URL]
- Botev R, "The clinician and estimation of glomerular filtration rate by creatinine-based formulas : current limitations and quo vadis", Clin J Am Soc Nephrol, 6(4), pp.937~950 (2011)
- Dinwiddie LC, "Stage 4chronic kidney disease : preserving kidney function and preparing patients for stage 5 kidney disease", Am J Nurs, 106(9), pp.40~51 (2006)
- Lakshman SG, "A comparative study of neurological complications in chronic kidney disease with special reference to its stages and haemodialysis status", J Clin Diagn Res, 10(12), pp.OC01~OC04 (2016)
- "Chapter 2: identification and care of patients with CKD" (2016)[URL]
- Ceriello A., "The glucose triad and its role in comprehensive glycaemic control: current status, future management", Int J Clin Pract, 64(12), pp.1705~1711 (2010)
- Hintsa S, "Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: a case-control study", PLoS One, 12(4), pp.e0173566~ (2017)
- Simon de Lusignan, "Informatics as Tool for Quality Improvement: Rapid Implementation of Guidance for the Management of Chronic Kidney Disease in England as an Exemplar", Healthcare Informatics Research, 19(1), pp.9~15 (2013), 대한의료정보학회[DOI]
- Yamamoto T, "Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages : the Gonryo study", Clin Exp Nephrol, 20(4), pp.595~602 (2016)
- Eka Miranda, "Detection of Cardiovascular Disease Risk’s Level for Adults Using Naive Bayes Classifier", Healthcare Informatics Research, 22(3), pp.196~205 (2016), 대한의료정보학회[DOI]
- 문미경, "Applying of Decision Tree Analysis to Risk Factors Associated with Pressure Ulcers in Long-Term Care Facilities", Healthcare Informatics Research, 23(1), pp.43~52 (2017), 대한의료정보학회[DOI]
- Tsai CW, "Longitudinal change in estimated GFR among CKD patients: a 10-year follow-up study of an integrated kidney disease care program in Taiwan", PLoS One, 12(4), pp.e0173843~ (2017)
- "Healthline. ALP (alkaline phosphatase level) test" (2017)[URL]
- Kim JH, "Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes", World J Gastroenterol, 16(14), pp.1782~1787 (2010)
- Idorn T, "Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease", Kidney Int, 83(5), pp.915~923 (2013)
- "Serum alkaline phosphatase has prognostic importance in chronic kidney disease: increasing levels signal higher risks of ESRD, mortality" (2014)[URL]
- Chang WX, "The impact of normal range of serum phosphorus on the incidence of end-stage renal disease by a propensity score analysis", PLoS One, 11(4), pp.e0154469~ (2016)
- DSa J, "Association between serum cystatin C and creatinine in chronic kidney disease subjects attending a tertiary health care centre", J Clin Diagn Res, 11(4), pp.BC09~BC12 (2017)
- "African Americans and kidney disease" (2017)[URL]
- Tussing-Humphreys LM, "A church-based pilot study designed to improve dietary quality for rural, lower Mississippi Delta, African American adults", J Relig Health, 54(2), pp.455~469 (2015)
- Tucker KL, "A regional food-frequency questionnaire for the US Mississippi Delta", Public Health Nutr, 8(1), pp.87~96 (2005)
- Zyga S, "Malnutritioninflammation-atherosclerosis syndrome in patients with end-stage renal disease", J Ren Care, 37(1), pp.12~15 (2011)
- "MedlinePlus. BUN - blood test" (2017)[URL]
- "Anion gap" (2017)[URL]
- Orth SR., "Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function", J Am Soc Nephrol, 15(Suppl 1), pp.S58~S63 (2004)
- "Urine albumin and albumin/creatinine ratio" (2017)[URL]